SUBSCRIBE
SUBSCRIBE

Amanda Heidt

Amanda is an award-winning freelance science journalist and editor covering everything from ecology and the environment to artificial intelligence and the nitty-grittiest cell and molecular biology. You can find her full portfolio and contact information at www.amandaheidt.com, or follow along on Bluesky and LinkedIn.

A rocket rapidly approaches its destination/Nicole
Drug Development
The Next Generation of Weight Loss Drugs is Rapidly Approaching
Successful drugs from Novo Nordisk and Eli Lilly are just the beginning of what one analyst says could be “the largest therapeutic class of drugs that the biopharma industry has ever seen.”
November 15, 2023
 · 
5 min read
 · 
Amanda Heidt
Pictured: A psychedelic therapy walks down the roa
Drug Development
Psychedelics Poised for the Therapeutic Mainstream
With the potential FDA approval of an MDMA-based therapy for PTSD on the horizon, biopharma stakeholders are eyeing psychedelics with fresh anticipation.
October 25, 2023
 · 
5 min read
 · 
Amanda Heidt
A moving truck parked in San Francisco’s Nob Hill
BioForest
How the Pandemic Shifted the Rules of Recruiting
Traditional ideas of what attracts talent have, in many ways been upended, with some locations faring better than others. And what employees look for in a job is still changing.
October 25, 2023
 · 
4 min read
 · 
Amanda Heidt
Pictured: Man holding a cell phone in front of com
Deals
5 Life Sciences IPOs in 2023—and the Future Forecast
After a sluggish start to the year, experts expect an uptick in IPO offerings moving into fall, although it’s unlikely 2023 will fully shrug off its slump.
September 19, 2023
 · 
5 min read
 · 
Amanda Heidt
Pictured: Row of black computer servers with small
Drug Development
Natural History Studies Drive Data Sharing, Drug Approval
Longitudinal studies that track patients’ experiences can inform and accelerate the drug approval process for rare diseases.
April 27, 2023
 · 
5 min read
 · 
Amanda Heidt
micrograph of pancreas tissue, typical pancreatic tissue in the jejunum tissue
Aspect Biosystems and Novo Nordisk to Tackle Type 1 Diabetes and Obesity
The new partnership involves an initial payout of $75 million and the potential for up to $2.6 billion in milestone funding.
April 13, 2023
 · 
4 min read
 · 
Amanda Heidt
Al Drago/CQ Roll Call
Drug Development
Medicare Provides Further Details About Planned Coverage of Leqembi
The Centers for Medicare and Medicaid Services released details about the patient registry it will require physicians to use to prescribe Leqembi, should it be approved by the FDA.
April 4, 2023
 · 
7 min read
 · 
Amanda Heidt